Drug Cost Management Report

View more issues:

Articles in Sept 12, 2003 issue of Drug Cost Management Report

• Specialty pharmacy market offers expansion opportunity for PBMs
• Mail-order rates, capabilities foster increased competitiveness among PBMs
• IRS says FSAs can pay for OTCs - flexible spending accounts can pay for over-the-counter drugs
• Ability to translate size into efficiencies seen as key in Caremark-AdvancePCS deal - Caremark Rx Inc. to acquire AdvancePCS Inc
• A new study shows inappropriate use of antibiotics is decreasing, at least among children - Brief Article
• Maximizing value of OTC drug conversions in payer populations - over-the-counter
  by Tim Watson
• More than half of prescription drug costs in workers' compensation cases are attributed to pain relievers - 55% - Brief Article
• AdvancePCS ingredient costs higher than industry average
• Crestor ripple likely minor, statin costs on rise, experts say
• The Pharmaceutical Care Management Assn. filed a lawsuit Sept. 3 seeking to prevent a Maine law requiring PBMs to disclose certain business information from taking effect - Brief Article
• Express Scripts has demonstrated that some expensive drugs may be less cost-effective than previously thought - Brief Article